Market Research Report
Global Absorbable Hemostat Market Insights, Forecast to 2028
|Global Absorbable Hemostat Market Insights, Forecast to 2028|
Published: January 12, 2022
Content info: 187 Pages
Delivery time: 2-3 business days
Due to the COVID-19 pandemic, the global Absorbable Hemostat market size is estimated to be worth US$ 2565.01 million in 2022 and is forecast to a readjusted size of US$ 3838.61 million by 2028 with a CAGR of 6.95% during the review period. Fully considering the economic change by this health crisis, Hemostatic Gauze accounting for 50.29% of the Absorbable Hemostat global market in 2021, is projected to value US$ 1945.52 million by 2028, growing at a revised 7.08% CAGR in the post-COVID-19 period. While Hospital segment is altered to an 8.64% CAGR throughout this forecast period.
China Absorbable Hemostat market size is valued at US$ 275.16 million in 2021, while the US and Europe Absorbable Hemostat are US$ 755.73 million and US$ 665.43 million, severally. The proportion of the US is 31.56% in 2021, while China and Europe are 11.49% and 27.79% respectively, and it is predicted that China proportion will reach 12.29% in 2028, trailing a CAGR of 7.97% through the analysis period. Japan, South Korea, and India are noteworthy markets in Asia, with CAGR 7.84%, 7.97%, and 8.01% respectively for the next 6-year period. As for the Europe Absorbable Hemostat landscape, Germany is projected to reach US$ 320.83 million by 2028 trailing a CAGR of 7.14% over the forecast period.
The global key manufacturers of Absorbable Hemostat include Johnson & Johnson, BD, Baxter, B.Braun, Curasan AG, etc. In 2021, the global top five players have a share approximately 62.89% in terms of revenue.
Absorbable Hemostat market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Absorbable Hemostat market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.